2280
Helvetica Chimica Acta Vol. 86 (2003)
334 (53), 275 (13), 252 (100), 193 (43), 165 (12), 156 (9), 86 (26). Anal. calc. for C29H33ClN2OS2 (525.18): C
66.32, H 6.33, N 5.33; found: C65.97, H 5.90, N 5.25.
3-[(1-Benzyl-4,5-diphenylimidazol-2-yl)disulfanyl]-3-chloro-2,2,4,4-tetramethylcyclobutanone (9c). Yield:
217 mg (41%). Yellowish crystals. M.p. 137 1398 (MeOH/CH2Cl2). IR: 1786vs (CO), 1603m, 1497s, 1443s,
1381s, 1352s, 1027s, 917m, 832m, 775s, 728s, 695vs. 1H-NMR: 1.35 (s, 2 Me); 1.43 (s, 2 Me); 5.25 (s, C H).
2
13C-NMR: 22.4 (q, 2 Me); 23.1 (q, 2 Me); 48.7 (t, C H); 69.3 (s, C(2), C(4)); 86.3 (s, C(3)); 126.3, 126.7, 127.6,
2
128.0, 128.6, 128.9, 129.1, 130.7 (8d, 15 arom. CH); 130.3, 132.5, 133.6, 136.7, 139.1, 140.1 (6s, 6 arom. C); 216.3
(s, CO). EI-MS: 532 (27, [M À 1] ), 283 (21), 252 (9), 193 (35), 156 (11), 91 (100). Anal. calc. for
C30H29ClN2OS2 (533.14): C67.58, H 5.48, N 5.25; found: C67.47, H 5.44, N 5.58.
5. Reaction of Thiouracil (2,3-Dihydro-2-thioxopyrimidin-4(1H)-one; 10) with 3. To a stirred suspension
of 10 (192.0 mg, 1.5 mmol) and Et3N (152 mg, 1.5 mmol) in CH2Cl2 (1 ml) was added a soln. of freshly distilled 3
(218.0 mg, 1 mmol) in CH2Cl2 (2 ml) at r.t. When the addition was complete, stirring was continued for 20 min,
then CH2Cl2 (5 ml) was added, the soln. was washed with 2% HCl (10 ml) and H2O (10 ml, 2 Â ). The org. phase
was separated, dried (MgSO4), and evaporated. The crude product was purified by recrystallization.
2-[(1-Chloro-2,2,4,4-tetramethyl-3-oxocyclobutyl)disulfanyl]pyrimidin-4(3H)-one (11). Yield: 210 mg
(66%). Colorless crystals. M.p. 142 1448 (hexane/CH2Cl2). IR: 1790s (CO, ketone), 1690vs (CO,
1
pyrimidone), 1480s, 1430s, 1250s, 980m, 820s. H-NMR: 1.46 (s, 2 Me); 1.55 (s, 2 Me); 6.27, 7.80 (AB, J 7.95,
2 H). 13C-NMR: 22.2 (q, 2 Me); 23.6 (q, 2 Me); 69.6 (s, C (2'), C(4')); 87.2 (s, C (1')); 113.1, 153.8 (2d, C (5),
.
C(6)); 161.0, 158.2 (2s, C(2), C(4)); 214.0 (s, CO). EI-MS: 318 (4, M ), 249 (16), 224 (29), 213 (100), 197
(24), 148 (11), 131 (66). Anal. calc. for C12H15ClN2O2S2 (318.85): C45.20, H 4.74, N 8.78; found: C44.77, H 4.62,
N 8.74.
6. Reaction of 12 with 3. A soln. of 12 (221 mg, 1 mmol) in CH2Cl2 (5 ml) was added to a stirred soln. of
freshly distilled 3 (227 mg, 1 mmol) in CH2Cl2 (5 ml). During the addition, the reaction flask was cooled in a
H2O/ice bath, then, the cooling bath was removed, and the mixture was stirred at r.t. After 24 h, the solvent was
evaporated, and the solid residue was separated by prep. TLC(SiO 2; hexane/Et2O 20 :1). Along with recovered
starting material 12 (92 mg, 42%), the oxo analogue 13 (54 mg, 26%) and a solid identified as 14 (22 mg, 7%)
were isolated as main fractions.
4,4-Dimethyl-2-phenyl-1,3-thiazol-5(4H)-one (13). Yield: 54 mg (26%). Yellowish oil. The 1H-NMR
spectrum of the isolated material was identical with that of an original sample of 12 [24].
5,5-Bis[1-chloro-2,2,4,4-tetramethyl-3-oxocyclobutyl)disulfanyl]-4,5-dihydro-4,4-dimethyl-2-phenyl-1,3-
thiazole (14). Yield: 22 mg (7%). Colorless crystals. M.p. 145 1478 (hexane). IR: 2977m, 1785vs (CO),
1447m, 1381m, 1260w, 949m, 835w, 767m. 1H-NMR: 1.39 (s, 2 Me); 1.41 (s, 2 Me); 1.43 (s, 2 Me); 1.49 (s, 2 Me);
1.60 (s, 2 Me); 7.38 7.47 (m, 3 arom. H); 7.83 7.86 (m, 2 arom. H). 13C-NMR: 22.2, 22.3, 22.9, 23.5, 24.0
(5q, 10 Me); 69.0, 69.7 (2s, 2 C(2'), 2 C(4')); 84.5, 85.5, 95.1 (3s, 2 C(1'), C(4), C(5)); 128.1, 128.4, 128.7 (3d, 5
arom. CH); 131.5 (s, 1 arom. C); 160.0 (s, CN); 216.0 (s, CO). Anal. calc. for C27H35Cl2NO2S5 (635.06): C
50.92, H 5.54, N 2.20; found: C50.04, H 5.43, N 2.01.
7. Reaction of 8b with 165). A soln. of freshly distilled 16 (52.0 mg, 0.20 mmol) in CH2Cl2 (0.5 ml) was added
dropwise to a stirred soln. of 8b (70 mg, 0.21 mmol) and Et3N (20 mg, 0.20 mmol) cooled in a H2O/ice bath. The
exothermic reaction was complete after 15 min. Then, the mixture was diluted with 10 ml CH2Cl2, extracted with
H2O (10 ml, 3 Â ), and the org. phase was dried (MgSO4). The solvent was evaporated, and the solid residue was
purified by crystallization.
3-Chloro-3-[(1-cyclohexyl-4,5-diphenyl-1H-imidazol-2-yl)trisulfanyl]-2,2,4,4-tetramethylcyclobutanone
(17). Yield: 79 mg (70%). Yellow crystals. M.p. 180 1828 (hexane/CH2Cl2). IR: 2933s, 1792vs (CO), 1444m,
1332w, 1027w, 825w, 776w, 699s. 1H-NMR: 0.75 1.90 (m, 10 H); 1.39 (s, 2 Me); 1.41 (s, 2 Me); 4.10 4.40
(m, 1 H); 7.04 7.42 (m, 10 arom. H). 13C-NMR: 22.9 (q, 2 Me); 23.6 (q, 2 Me); 25.2, 26.4, 33.6 (3t, 5 C H); 59.0
2
(d, CH); 69.6 (2s, C(2), C(4)); 88.3 (s, C(3)); 127.0, 127.2, 128.3, 129.2, 129.6 (5d, 10 arom. CH); 132.0, 132.8,
.
134.0, 139.5, 140.8 (5s, 5 arom. C); 216.2 (s, CO). EI-MS: 557 (<1, M ), 556 (4, [M À 1] ), 334 (100), 333
(32). Anal. calc. for C29H33ClN2OS3 (557.24): C62.51, H 5.97, N 5.03; found: C62.10, H 5.98, N 5.24.
8. Reaction of 10 with 16. To a stirred suspension of 10 (192 mg, 1.50 mmol) and Et3N (152 mg, 1.50 mmol)
in CH2Cl2 (1 ml) was added dropwise at r.t. a soln. of freshly distilled 16 (259 mg, 1.00 mmol) in CH2Cl2 (2 ml).
After 20 min stirring, CH2Cl2 (5 ml) was added, and the mixture was washed with 2% HCl (10 ml) and H2O
(10 ml, 2 Â ). The org. phase was dried (MgSO4) and evaporated to give a crystalline, colorless solid.
Crystallization of the crude product afforded an anal. pure sample.
5
¬
¬
Experiment performed by K. Tegos, University of Ëodz, 2002.
)